Dr. Jacques Bradwejn trained in medicine at the University of Sherbrooke and in psychiatry at McGill University. He completed a research fellowship in psychopharmacology at McGill University and in neuropsychopharmacology at the University of Montreal. Dr. Bradwejn has also completed the Wharton Certificate of Professional Development at the Wharton School, University of Pennsylvania and has been a member of the Wharton Fellows Program.
Before serving at the Deanship, Dr. Bradwejn served as Chair of the Department of Psychiatry of the University of Ottawa and as Psychiatrist-in-Chief at the Royal Ottawa Hospital, positions he has held since January 1998, and as Head of Psychiatry of The Ottawa Hospital since January 1999. He has also held positions at McGill University as Associate Professor of Psychiatry and at the University of Toronto as Professor of Psychiatry.
Dr. Bradwejn has been actively involved in psychiatric and mental health research. His main research interest has been in the field of anxiety disorders for which he gained an international reputation. He was the first to hypothesize a role for the neuropeptide cholecystokinin (CCK) in the etiology of panic attacks in humans. He also carries out research on the integration of biological and psychological approaches in the treatment of anxiety disorders and to approaches used by Complementary Medicines.
He has published over 180 articles and book chapters, has made more than 400 scientific and educational conferences and over 350 educational media interventions.
As Dean of the Faculty of Medicine at the University of Ottawa, a top ranking Canadian Faculty in research, education and innovation, he is credited for the creation of an MD/PhD Program, an institute for innovation in medical devices (MDI2), a School of Epidemiology, Public Health and Preventative Medicine, a Department of Innovation in Medical Education, a Program of Medicine and the Humanities and one of the largest medical simulation center in North America (uOSSC).
Dr. Bradwejn was Chair of the Board of Directors of the Association of Faculties of Medicine of Canada (AFMC), from 2012 to 2014. He is also the Founding Dean and Visiting Professor at the Shanghai Jiao Tong University School of Medicine where he established with his Shanghai partners the Ottawa Shanghai Joint School of Medicine at Renji Hospital. It is the first initiative that introduces a western medical curriculum in China. Moreover, this international partnership is unique because it is based on an equal preferred partnership between two high ranking Faculties of Medicine of two different countries, that invest their resources together with the single aim of social accountability and service in their respective countries and internationally. It is also a partnership for leveraging resources for innovation in medicine and health.